Jinli Luo

2.7k total citations · 1 hit paper
63 papers, 2.0k citations indexed

About

Jinli Luo is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Analytical Chemistry. According to data from OpenAlex, Jinli Luo has authored 63 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 12 papers in Pulmonary and Respiratory Medicine and 10 papers in Analytical Chemistry. Recurrent topics in Jinli Luo's work include Analytical chemistry methods development (10 papers), Porphyrin Metabolism and Disorders (8 papers) and Cancer Genomics and Diagnostics (6 papers). Jinli Luo is often cited by papers focused on Analytical chemistry methods development (10 papers), Porphyrin Metabolism and Disorders (8 papers) and Cancer Genomics and Diagnostics (6 papers). Jinli Luo collaborates with scholars based in United Kingdom, China and United States. Jinli Luo's co-authors include C.K. Lim, Lynne Howells, Chang Kee Lim, Andreas J. Gescher, W P Steward, Simon Plummer, Donald J. L. Jones, Rebekah Jukes, Richard D. Verschoyle and Christopher R. Ireson and has published in prestigious journals such as PLoS ONE, Molecular and Cellular Biology and Analytical Chemistry.

In The Last Decade

Jinli Luo

58 papers receiving 2.0k citations

Hit Papers

Characterization of metabolites of the chemopreventive ag... 2001 2026 2009 2017 2001 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jinli Luo United Kingdom 22 996 490 400 374 260 63 2.0k
Arghya Adhikary India 32 1.2k 1.2× 338 0.7× 157 0.4× 477 1.3× 98 0.4× 82 2.6k
Shanshan Geng China 29 1.2k 1.2× 378 0.8× 268 0.7× 341 0.9× 128 0.5× 62 2.3k
Brigitte Marian Austria 36 2.3k 2.3× 664 1.4× 114 0.3× 1.1k 3.0× 222 0.9× 111 3.8k
Inamul Haque United States 29 904 0.9× 227 0.5× 46 0.1× 222 0.6× 72 0.3× 70 2.0k
Renata Kontek Poland 23 1.4k 1.5× 391 0.8× 80 0.2× 723 1.9× 274 1.1× 74 3.3k
Chao Han China 30 1.4k 1.5× 516 1.1× 29 0.1× 255 0.7× 158 0.6× 121 2.8k
Sepideh Mirzaei Iran 39 2.5k 2.5× 1.6k 3.3× 164 0.4× 633 1.7× 390 1.5× 69 4.0k
Zhiguo Liu China 29 1.3k 1.3× 206 0.4× 381 1.0× 267 0.7× 191 0.7× 115 3.1k
Woo Hyun Park South Korea 30 1.9k 1.9× 329 0.7× 114 0.3× 315 0.8× 159 0.6× 138 3.1k
Stefano Tiziani United States 26 1.7k 1.8× 748 1.5× 31 0.1× 299 0.8× 342 1.3× 80 3.0k

Countries citing papers authored by Jinli Luo

Since Specialization
Citations

This map shows the geographic impact of Jinli Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jinli Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jinli Luo more than expected).

Fields of papers citing papers by Jinli Luo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jinli Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jinli Luo. The network helps show where Jinli Luo may publish in the future.

Co-authorship network of co-authors of Jinli Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Jinli Luo. A scholar is included among the top collaborators of Jinli Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jinli Luo. Jinli Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhao, Shuangshuang, et al.. (2025). PFKFB4 promotes endometrial cancer by regulating glycolysis through SRC‑3 phosphorylation. Oncology Reports. 53(5). 1–12.
3.
Zhou, Ling, Jinli Luo, Yu Wei, et al.. (2025). Dioscorea nipponica Makino: Unraveling multi-target mechanisms and clinical potential in autoimmune disease therapy. Journal of Ethnopharmacology. 353(Pt A). 120272–120272.
4.
Luo, Jinli, Shaohua Zhang, Peiqi Liu, et al.. (2025). Differential detection of ovine Theileria species using loop-mediated isothermal amplification combined with nanoparticle-based lateral flow biosensor. Veterinary Parasitology. 336. 110443–110443.
5.
Luo, Jinli, et al.. (2024). A prognostic model based on DNA methylation-related gene expression for predicting overall survival in hepatocellular carcinoma. Frontiers in Oncology. 13. 1171932–1171932. 7 indexed citations
6.
Zeng, Wen, Zenghui Hu, Jinli Luo, Xiandeng Hou, & Xiaoming Jiang. (2021). Highly sensitive determination of trace antimony in water samples by cobalt ion enhanced photochemical vapor generation coupled with atomic fluorescence spectrometry or ICP-MS. Analytica Chimica Acta. 1191. 339361–339361. 24 indexed citations
8.
Busacca, Sara, Qi Zhang, Annabel Sharkey, et al.. (2021). Transcriptional perturbation of protein arginine methyltransferase-5 exhibits MTAP-selective oncosuppression. Scientific Reports. 11(1). 7434–7434. 5 indexed citations
9.
Kamata, Tamihiro, Qasim Ahmed, Susan Giblett, et al.. (2020). Fibroblast-Derived STC-1 Modulates Tumor-Associated Macrophages and Lung Adenocarcinoma Development. Cell Reports. 31(12). 107802–107802. 25 indexed citations
10.
Alexandrou, Constantia, Jennifer A. Higgins, William Boyle, et al.. (2018). Sensitivity of Colorectal Cancer to Arginine Deprivation Therapy is Shaped by Differential Expression of Urea Cycle Enzymes. Scientific Reports. 8(1). 12096–12096. 67 indexed citations
11.
Shaw, Jacqui, David S. Guttery, Allison Hills, et al.. (2016). Mutation Analysis of Cell-Free DNA and Single Circulating Tumor Cells in Metastatic Breast Cancer Patients with High Circulating Tumor Cell Counts. Clinical Cancer Research. 23(1). 88–96. 171 indexed citations
12.
Busacca, Sara, Ian Powley, David A. Proia, et al.. (2015). Resistance to HSP90 inhibition involving loss of MCL1 addiction. Oncogene. 35(12). 1483–1492. 24 indexed citations
13.
Yu, Lei, Tao Huang, Meng Su, et al.. (2014). Expression and distribution of immunoglobulin G in the normal liver, hepatocarcinoma and postpartial hepatectomy liver. Laboratory Investigation. 94(11). 1283–1295. 18 indexed citations
14.
Chen, Zhengshan, Junjun Zhang, Jing Li, et al.. (2011). Transcription Factors E2A, FOXO1 and FOXP1 Regulate Recombination Activating Gene Expression in Cancer Cells. PLoS ONE. 6(5). e20475–e20475. 20 indexed citations
15.
Lord, Gwyn A., et al.. (2000). HPLC-electrospray mass spectrometry for the analysis of temoporfin-poly(ethylene glycol) conjugates. The Analyst. 125(4). 605–608. 1 indexed citations
16.
Cai, Hong, Qiang Wang, Jinli Luo, & C.K. Lim. (1999). Study of temoporfin metabolism by HPLC and electrospray mass spectrometry. Biomedical Chromatography. 13(5). 354–359. 13 indexed citations
18.
20.
Luo, Jinli & C.K. Lim. (1991). Random decarboxylation of uroporphyrinogen III by human hepatic uroporphyrinogen decarboxylase. Journal of Chromatography B Biomedical Sciences and Applications. 566(2). 409–413. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026